Dengue: an arthropod-borne disease of global importance

  • A. T. A. Mairuhu
  • J. Wagenaar
  • D. P. M. Brandjes
  • E. C. M. van Gorp


Dengue viruses cause a variable spectrum of disease that ranges from an undifferentiated fever to dengue fever to the potentially fatal dengue shock syndrome. Due to the increased incidence and geographical distribution of dengue in the last 50 years, dengue is becoming increasingly recognised as one of the world’s major infectious diseases. This article will review clinical and diagnostic aspects of dengue virus infections. It also presents our current knowledge of the pathophysiology of severe dengue and addresses the importance of dengue virus infections in those travelling to parts of the world where dengue is endemic.


  1. 1.
    Guzman MG, Kouri G (2002) Dengue: an update. Lancet Infect Dis 2:33–42CrossRefPubMedGoogle Scholar
  2. 2.
    Kuhn RJ, Zhang W, Rossmann MG et al (2002) Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108:717–725CrossRefPubMedGoogle Scholar
  3. 3.
    Henchal EA, Putnak JR (1990) The dengue viruses. Clin Microbiol Rev 3:376–396PubMedGoogle Scholar
  4. 4.
    Rigau-Perez JG, Clark GG, Gubler DJ et al (1998) Dengue and dengue haemorrhagic fever. Lancet 352:971–977CrossRefPubMedGoogle Scholar
  5. 5.
    Vazeille-Falcoz M, Adhami J, Mousson L, Rodhain F (1999) Aedes albopictus from Albania: a potential vector of dengue viruses. J Am Mosq Control Assoc 15:475–478PubMedGoogle Scholar
  6. 6.
    Romi R, Di Luca M, Majori G (1999) Current status of Aedes albopictus and Aedes atropalpus in Italy. J Am Mosq Control Assoc 15:425–427PubMedGoogle Scholar
  7. 7.
    Schaffner F, Karch S (2000) First report of Aedes albopictus (Skuse, 1984) in metropolitan France. C R Acad Sci III 323:373–375CrossRefPubMedGoogle Scholar
  8. 8.
    Hales S, de Wet N, Maindonald J, Woodward A (2002) Potential effect of population and climate changes on global distribution of dengue fever: an empirical model. Lancet 360:830–834CrossRefPubMedGoogle Scholar
  9. 9.
    Kautner I, Robinson MJ, Kuhnle U (1997) Dengue virus infection: epidemiology, pathogenesis, clinical presentation, diagnosis, and prevention. J Pediatr 131:516–524PubMedGoogle Scholar
  10. 10.
    Hammon WM, Rudnick A, Sather G et al (1960) New hemorrhagic fevers of children in the Philippines and Thailand. Trans Assoc Am Physicians 73:140–155PubMedGoogle Scholar
  11. 11.
    Kouri G, Mas P, Guzman MG et al (1983) Dengue hemorrhagic fever in Cuba, 1981: rapid diagnosis of the etiologic agent. Bull Pan Am Health Organ 17:126–132PubMedGoogle Scholar
  12. 12.
    World Health Organisation (1997) Dengue hemorrhagic fever: diagnosis, treatment, prevention and control, 2nd edn. WHO, GenevaGoogle Scholar
  13. 13.
    Ellerin T, Hurtado R, Lockman S, Baden L (2003) Fever in a returned traveler: an “off the cuff” diagnosis. Clin Infect Dis 36:1004–1005, 1074–1075CrossRefPubMedGoogle Scholar
  14. 14.
    Nimmannitya S (1987) Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 18:392–397PubMedGoogle Scholar
  15. 15.
    Sumarmo, Wulur H, Jahja E et al (1983) Clinical observations on virologically confirmed fatal dengue infections in Jakarta, Indonesia. Bull World Health Organ 61:693–701PubMedGoogle Scholar
  16. 16.
    Guzman MG, Alvarez M, Rodriguez R et al (1999) Fatal dengue hemorrhagic fever in Cuba, 1997. Int J Infect Dis 3:130–135CrossRefPubMedGoogle Scholar
  17. 17.
    Zagne SM, Alves VG, Nogueira RM et al (1994). Dengue haemorrhagic fever in the state of Rio de Janeiro, Brazil: a study of 56 confirmed cases. Trans R Soc Trop Med Hyg 88:677–679CrossRefPubMedGoogle Scholar
  18. 18.
    Rigau-Perez JG (1997) Clinical manifestations of dengue hemorrhagic fever in Puerto Rico, 1990–1991. Puerto Rico Association of Epidemiologists. Rev Panam Salud Publica 1:381–388PubMedGoogle Scholar
  19. 19.
    Kalayanarooj S, Vaughn DW, Nimmannitya S et al (1997) Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 176:313–321PubMedGoogle Scholar
  20. 20.
    Solomon T, Dung NM, Vaughn DW et al (2000) Neurological manifestations of dengue infection. Lancet 355:1053–1059CrossRefPubMedGoogle Scholar
  21. 21.
    Lawn SD, Tilley R, Lloyd G et al (2003) Dengue hemorrhagic fever with fulminant hepatic failure in an immigrant returning to Bangladesh. Clin Infect Dis 37:e1–e4CrossRefPubMedGoogle Scholar
  22. 22.
    Haritoglou C, Dotse SD, Rudolph G et al (2002) A tourist with dengue fever and visual loss. Lancet 360:1070CrossRefPubMedGoogle Scholar
  23. 23.
    Haritoglou C, Scholz F, Bialasiewicz A, Klauss V (2000) Ocular manifestation in dengue fever. Ophthalmologe 97:433–436CrossRefPubMedGoogle Scholar
  24. 24.
    Bhamarapravati N (1989) Hemostatic defects in dengue hemorrhagic fever. Rev Infect Dis 11(Suppl 4):826–829Google Scholar
  25. 25.
    Bhamarapravati N, Tuchinda P, Boonyapaknavik V (1967) Pathology of Thailand haemorrhagic fever: a study of 100 autopsy cases. Ann Trop Med Parasitol 61:500–510PubMedGoogle Scholar
  26. 26.
    Huerre MR, Lan NT, Marianneau P et al (2001) Liver histopathology and biological correlates in five cases of fatal dengue fever in Vietnamese children. Virchows Arch 438:107–115PubMedGoogle Scholar
  27. 27.
    Couvelard A, Marianneau P, Bedel C et al (1999) Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis. Hum Pathol 30:1106–1110PubMedGoogle Scholar
  28. 28.
    Rosen L, Khin MM, Tin U (1989) Recovery of virus from the liver of children with fatal dengue: reflections on the pathogenesis of the disease and its possible analogy with that of yellow fever. Res Virol 140:351–360PubMedGoogle Scholar
  29. 29.
    Sahaphong S, Riengrojpitak S, Bhamarapravati N, Chirachariyavej T (1980) Electron microscopic study of the vascular endothelial cell in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 11:194–204PubMedGoogle Scholar
  30. 30.
    Bokisch VA, Top FH Jr, Russell PK, Dixon FJ, Muller-Eberhard HJ (1973) The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med 289:996–1000PubMedGoogle Scholar
  31. 31.
    Green S, Vaughn DW, Kalayanarooj S et al (1999) Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 179:755–762PubMedGoogle Scholar
  32. 32.
    Mairuhu AT, Mac Gillavry MR, Setiati TE et al (2003) Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence. Lancet Infect Dis 3:33–41CrossRefPubMedGoogle Scholar
  33. 33.
    Vaughn DW, Green S, Kalayanarooj S et al (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181:2–9CrossRefPubMedGoogle Scholar
  34. 34.
    Burke DS, Nisalak A, Johnson DE, Scott RM (1988) A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 38:172–180PubMedGoogle Scholar
  35. 35.
    Halstead SB, Nimmannitya S, Cohen SN (1970) Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med 42:311–328PubMedGoogle Scholar
  36. 36.
    Russell PK, Yuill TM, Nisalak A et al (1968) An insular outbreak of dengue hemorrhagic fever. II. Virologic and serologic studies. Am J Trop Med Hyg 17:600–608PubMedGoogle Scholar
  37. 37.
    Sangkawibha N, Rojanasuphot S, Ahandrik S et al (1984) Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 120:653–669PubMedGoogle Scholar
  38. 38.
    Kurane I, Meager A, Ennis FA (1989) Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity. J Exp Med 170:763–775PubMedGoogle Scholar
  39. 39.
    Kliks SC, Nimmanitya S, Nisalak A, Burke DS (1988) Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 38:411–419PubMedGoogle Scholar
  40. 40.
    Martinez E, Guzman MG, Valdes M, Soler M, Kouri G (1993) Dengue fever and hemorrhagic dengue in infants with a primary infection. Rev Cubana Med Trop 45:97–101PubMedGoogle Scholar
  41. 41.
    Scott RM, Nimmannitya S, Bancroft WH, Mansuwan P (1976) Shock syndrome in primary dengue infections. Am J Trop Med Hyg 25:866–874PubMedGoogle Scholar
  42. 42.
    Morens DM, Sather GE, Gubler DJ, Rammohan M, Woodall JP (1987) Dengue shock syndrome in an American traveler with primary dengue 3 infection. Am J Trop Med Hyg 36:424–426PubMedGoogle Scholar
  43. 43.
    Guzman MG, Kouri G, Bravo J et al (2002) Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis 6:118–124CrossRefPubMedGoogle Scholar
  44. 44.
    Kouri GP, Guzman MG, Bravo JR, Triana C (1989) Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. Bull World Health Organ 67:375–380PubMedGoogle Scholar
  45. 45.
    Gamble J, Bethell D, Day NP et al (2000) Age-related changes in microvascular permeability: a significant factor in the susceptibility of children to shock? Clin Sci (Lond) 98:211–216Google Scholar
  46. 46.
    Guzman MG, Kouri GP, Bravo J et al (1990) Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg 42:179–184PubMedGoogle Scholar
  47. 47.
    Loke H, Bethell D, Phuong CX et al (2002) Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin D receptor and Fc gamma receptor IIa genes. Am J Trop Med Hyg 67:102–106PubMedGoogle Scholar
  48. 48.
    Loke H, Bethell DB, Phuong CX et al (2001) Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? J Infect Dis 184:1369–1373CrossRefPubMedGoogle Scholar
  49. 49.
    Stephens HA, Klaythong R, Sirikong M et al (2002) HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 60:309–318CrossRefPubMedGoogle Scholar
  50. 50.
    Wang WK, Chao DY, Kao CL et al (2003) High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology 305:330–338CrossRefPubMedGoogle Scholar
  51. 51.
    Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV (1992) Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30:545–551PubMedGoogle Scholar
  52. 52.
    Morita K, Maemoto T, Honda S et al (1994) Rapid detection of virus genome from imported dengue fever and dengue hemorrhagic fever patients by direct polymerase chain reaction. J Med Virol 44:54–58PubMedGoogle Scholar
  53. 53.
    Warrilow D, Northill JA, Pyke A, Smith GA (2002) Single rapid TaqMan fluorogenic probe based PCR assay that detects all four dengue serotypes. J Med Virol 66:524–528CrossRefPubMedGoogle Scholar
  54. 54.
    Sudiro TM, Zivny J, Ishiko H et al (2001) Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction. J Med Virol 63:29–34CrossRefPubMedGoogle Scholar
  55. 55.
    Young PR, Hilditch PA, Bletchly C, Halloran W (2000) An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol 38:1053–1057PubMedGoogle Scholar
  56. 56.
    Koraka P, Burghoorn-Maas CP, Falconar A et al (2003) Detection of immune-complex-dissociated nonstructural-1 antigen in patients with acute dengue virus infections. J Clin Microbiol 41:4154–4159CrossRefPubMedGoogle Scholar
  57. 57.
    Alcon S, Talarmin A, Debruyne M et al (2002) Enzyme-linked immunosorbent assay specific to dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 40:376–381CrossRefPubMedGoogle Scholar
  58. 58.
    Vaughn DW, Green S, Kalayanarooj S et al (1997) Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis 176:322–330Google Scholar
  59. 59.
    Cuzzubbo AJ, Vaughn DW, Nisalak A et al (2000) Comparison of PanBio Dengue Duo IgM and IgG capture ELISA and Venture Technologies Dengue IgM and IgG dot blot. J Clin Virol 16:135–144CrossRefPubMedGoogle Scholar
  60. 60.
    Miagostovich MP, Nogueira RM, dos Santos FB et al (1999) Evaluation of an IgG enzyme-linked immunosorbent assay for dengue diagnosis. J Clin Virol 14:183–189CrossRefPubMedGoogle Scholar
  61. 61.
    Vaughn DW, Nisalak A, Kalayanarooj S et al (1998) Evaluation of a rapid immunochromatographic test for diagnosis of dengue virus infection. J Clin Microbiol 36:234–238PubMedGoogle Scholar
  62. 62.
    Branch SL, Levett PN (1999) Evaluation of four methods for detection of immunoglobulin M antibodies to dengue virus. Clin Diagn Lab Immunol 6:555–557PubMedGoogle Scholar
  63. 63.
    Wu SJ, Paxton H, Hanson B et al (2000) Comparison of two rapid diagnostic assays for detection of immunoglobulin M antibodies to dengue virus. Clin Diagn Lab Immunol 7:106–110PubMedGoogle Scholar
  64. 64.
    Groen J, Koraka P, Velzing J, Copra C, Osterhaus AD (2000) Evaluation of six immunoassays for detection of dengue virus-specific immunoglobulin M and G antibodies. Clin Diagn Lab Immunol 7:867–871CrossRefPubMedGoogle Scholar
  65. 65.
    Halstead SB, Deen J (2002) The future of dengue vaccines. Lancet 360:1243–1245CrossRefPubMedGoogle Scholar
  66. 66.
    Monath TP, McCarthy K, Bedford P et al (2002) Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections. Vaccine 20:1004–1018CrossRefPubMedGoogle Scholar
  67. 67.
    Guirakhoo F, Pugachev K, Arroyo J et al (2002) Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates. Virology 298:146–159CrossRefPubMedGoogle Scholar
  68. 68.
    Guirakhoo F, Arroyo J, Pugachev KV et al (2001) Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. J Virol 75:7290–7304CrossRefPubMedGoogle Scholar
  69. 69.
    Winch PJ, Leontsini E, Rigau-Perez JG et al (2002) Community-based dengue prevention programs in Puerto Rico: impact on knowledge, behavior, and residential mosquito infestation. Am J Trop Med Hyg 67:363–370PubMedGoogle Scholar
  70. 70.
    Degallier N, Vilarinhos PT, de Carvalho MS, Knox MB, Caetano J Jr (2000) People’s knowledge and practice about dengue, its vectors, and control means in Brasilia (DF), Brazil: its relevance with entomological factors. J Am Mosq Control Assoc 16:114–123PubMedGoogle Scholar
  71. 71.
    Iyngkaran N, Yadav M, Harun F, Kamath KR (1992) Augmented tumour necrosis factor in Reye’s syndrome associated with dengue virus. Lancet 340:1466–1467CrossRefGoogle Scholar
  72. 72.
    Terry SI, Golden MH, Hanchard B, Bain B (1980) Adult Reye’s syndrome after dengue. Gut 21:436–438PubMedGoogle Scholar
  73. 73.
    Ngo NT, Cao XT, Kneen R et al (2001) Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis 32:204–213CrossRefPubMedGoogle Scholar
  74. 74.
    Dung NM, Day NP, Tam DT et al (1999) Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens. Clin Infect Dis 29:787–794PubMedGoogle Scholar
  75. 75.
    Tassniyom S, Vasanawathana S, Dhiensiri T, Nisalak A, Chirawatkul A (1997) Failure of carbazochrome sodium sulfonate (AC-17) to prevent dengue vascular permeability or shock: a randomized, controlled trial. J Pediatr 131:525–528PubMedGoogle Scholar
  76. 76.
    Tassniyom S, Vasanawathana S, Chirawatkul A, Rojanasuphot S (1993) Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics 92:111–115PubMedGoogle Scholar
  77. 77.
    Leong KW, Srinivas P (1993) Corticosteroid-responsive prolonged thrombocytopenia following dengue haemorrhagic fever. Med J Malaysia 48:369–372PubMedGoogle Scholar
  78. 78.
    Ostronoff M, Ostronoff F, Florencio R et al (2003) Serious thrombocytopenia due to dengue hemorrhagic fever treated with high dosages of immunoglobulin. Clin Infect Dis 36:1623–1624CrossRefPubMedGoogle Scholar
  79. 79.
    Pea L, Roda L, Moll F (2001) Desmopressin treatment for a case of dengue hemorrhagic fever/dengue shock syndrome. Clin Infect Dis 33:1611–1612CrossRefPubMedGoogle Scholar
  80. 80.
    Chuansumrit A, Chantarojanasiri T, Isarangkura P et al (2000) Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation. Blood Coagul Fibrinolysis 11(Suppl 1):101–105PubMedGoogle Scholar
  81. 81.
    Dengue: current epidemics and risks to travellers (1995) Commun Dis Rep CDR Wkly 5:201PubMedGoogle Scholar
  82. 82.
    Jelinek T (2000) Dengue fever in international travellers. Clin Infect Dis 31:144–147CrossRefPubMedGoogle Scholar
  83. 83.
    Lopez-Velez R, Perez-Casas C, Vorndam AV, Rigau J (1996) Dengue in Spanish travelers returning from the tropics. Eur J Clin Microbiol Infect Dis 15:823–826PubMedGoogle Scholar
  84. 84.
    Schwarz TF, Jager G, Gilch S (1995) Imported dengue virus infections in German tourists. Zentralbl Bakteriol 282:533–536PubMedGoogle Scholar
  85. 85.
    Jacobs MG, Brook MG, Weir WR, Bannister BA (1991) Dengue haemorrhagic fever: a risk of returning home. Br Med J 302:828–829Google Scholar
  86. 86.
    Schwartz E, Mendelson E, Sidi Y (1996) Dengue fever among travelers. Am J Med 101:516–520CrossRefPubMedGoogle Scholar
  87. 87.
    Wittesjo B, Eitrem R, Niklasson B (1993) Dengue fever among Swedish tourists. Scand J Infect Dis 25:699–704PubMedGoogle Scholar
  88. 88.
    Trofa AF, DeFraites RF, Smoak BL et al (1997) Dengue fever in U.S. military personnel in Haiti. J Am Med Assoc 277:1546–1548CrossRefGoogle Scholar
  89. 89.
    Shirtcliffe P, Cameron E, Nicholson KG, Wiselka MJ (1998) Don’t forget dengue! Clinical features of dengue fever in returning travellers. J R Coll Physicians (Lond) 32:235–237Google Scholar
  90. 90.
    Jelinek T, Dobler G, Holscher M, Loscher T, Nothdurft HD (1997) Prevalence of infection with dengue virus among international travelers. Arch Intern Med 157:2367–2370CrossRefPubMedGoogle Scholar
  91. 91.
    Lindback H, Lindback J, Tegnell A, Janzon R, Vene S, Ekdahl K (2003) Dengue fever in travelers to the tropics, 1998 and 1999. Emerg Infect Dis 9:438–442PubMedGoogle Scholar
  92. 92.
    Jelinek T, Muhlberger N, Harms G et al (2002) Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop. Clin Infect Dis 35:1047–1052CrossRefPubMedGoogle Scholar
  93. 93.
    Potasman I, Srugo I, Schwartz E (1999) Dengue seroconversion among Israeli travelers to tropical countries. Emerg Infect Dis 5:824–827PubMedGoogle Scholar
  94. 94.
    O’Leary DR, Rigau-Perez JG, Hayes EB et al (2002) Assessment of dengue risk in relief workers in Puerto Rico after Hurricane Georges, 1998. Am J Trop Med Hyg 66:35–39PubMedGoogle Scholar
  95. 95.
    Schwartz E, Moskovitz A, Potasman I et al (2000) Changing epidemiology of dengue fever in travelers to Thailand. Eur J Clin Microbiol Infect Dis 19:784–786CrossRefPubMedGoogle Scholar
  96. 96.
    Cobelens FG, Groen J, Osterhaus AD et al (2002) Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia. Trop Med Int Health 7:331–338CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • A. T. A. Mairuhu
    • 1
  • J. Wagenaar
    • 1
  • D. P. M. Brandjes
    • 1
  • E. C. M. van Gorp
    • 1
  1. 1.Department of Internal MedicineSlotervaart HospitalAmsterdamThe Netherlands

Personalised recommendations